Literature DB >> 20034368

Advanced Diabetes care: three levels of prediction, prevention & personalized treatment.

Olga Golubnitschaja1.   

Abstract

Worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment approaches. Generally there are three levels in desirable pre- and Diabetes care: 1st level: prediction of the predisposition early in childhood. 2nd level: prediction of early/premature aging and prestages of Diabetes. 3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics. Predictive diagnosis is considered as the basis for targeted preventive measures and consequent creation of individualized treatment approaches. Communication among the professionals - healthcare providers, policy-makers, educators, etc., obligatory involved in the overall process to improving (pre)Diabetes care is of paramount importance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20034368     DOI: 10.2174/157339910790442637

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  11 in total

1.  Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.

Authors:  Kristina Yeghiazaryan; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2012-10

2.  Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.

Authors:  Kristina Yeghiazaryan; Viktoriya Peeva; Aparna Shenoy; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2011-04

Review 3.  Diabetes care in figures: current pitfalls and future scenario.

Authors:  Alexandre Assuane Duarte; Shahriar Mohsin; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-05-22       Impact factor: 6.543

4.  The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures?

Authors:  Yasmine Amr Issa; Samar Samy Abd ElHafeez; Noha Gaber Amin
Journal:  EPMA J       Date:  2019-08-06       Impact factor: 6.543

5.  Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-16       Impact factor: 6.543

6.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

7.  Inadequate diabetic care: global figures cry for preventive measures and personalized treatment.

Authors:  Babitha George; Melanie Cebioglu; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

8.  Neurodegeneration: accelerated ageing or inadequate healthcare?

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

9.  Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring 'anecdotes' of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2012-10-07       Impact factor: 6.543

10.  Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study.

Authors:  Ein Oh; Tae Keun Yoo; Eun-Cheol Park
Journal:  BMC Med Inform Decis Mak       Date:  2013-09-13       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.